These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24881147)

  • 1. Newcastle disease in captive falcons in the Middle East: a review of clinical and pathologic findings.
    Samour J
    J Avian Med Surg; 2014 Mar; 28(1):1-5. PubMed ID: 24881147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response of hybrid falcons inoculated with inactivated paramyxovirus-1 vaccine.
    Lloyd C; Wernery U
    J Avian Med Surg; 2008 Sep; 22(3):213-7. PubMed ID: 19014094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three experimental inactivated oil-emulsion Newcastle disease vaccines.
    Stone HD; Brugh M; Beard CW
    Avian Dis; 1981; 25(4):1070-6. PubMed ID: 7337607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus.
    Bolte AL; Voss M; Vielitz E; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):155-9. PubMed ID: 11370475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a commercial Newcastle vaccine against velogenic viscerotropic Newcastle disease virus.
    Benson HN; Wenger DR; Beard PD
    Avian Dis; 1975; 19(3):566-72. PubMed ID: 1164321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
    Folitse R; Halvorson DA; Sivanandan V
    Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of hemagglutination activity recovered from oil-emulsion Newcastle disease vaccines as a prediction of efficacy.
    Stone HD
    Avian Dis; 1985; 29(3):721-8. PubMed ID: 4074240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epizootiology of velogenic viscerotropic Newcastle disease in southern California, 1971-1973.
    Utterback WW; Schwartz JH
    J Am Vet Med Assoc; 1973 Nov; 163(9):1080-8. PubMed ID: 4747907
    [No Abstract]   [Full Text] [Related]  

  • 9. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge.
    Liljebjelke KA; King DJ; Kapczynski DR
    Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion Body Herpesvirus Hepatitis in Captive Falcons in the Middle East: A Review of Clinical and Pathologic Findings.
    Raghav R; Samour J
    J Avian Med Surg; 2019 Mar; 33(1):1-6. PubMed ID: 31124605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of viable and inactivated Newcastle disease virus vaccines in turkeys.
    Kelleher CJ; Halvorson DA; Newman JA
    Avian Dis; 1988; 32(2):342-6. PubMed ID: 3401177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants.
    Brugh M; Stone HD; Lupton HW
    Am J Vet Res; 1983 Jan; 44(1):72-5. PubMed ID: 6824228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.
    Beard CW; Villegas P; Glisson JR
    Avian Dis; 1993; 37(1):222-5. PubMed ID: 8452500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination of ostriches (Struthio camelus, Linnaeus, 1758) against Newcastle disease: evidence for vaccine compatibility and seroconversion after vaccinations using the hemagglutination inhibition and virus neutralization tests].
    Bolte AL; Voelckel K; Kaleta EF
    Dtsch Tierarztl Wochenschr; 1999 Feb; 106(2):62-5. PubMed ID: 10085579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.